rs34450592

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_006949.4(STXBP2):​c.849G>A​(p.Glu283Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00193 in 1,614,078 control chromosomes in the GnomAD database, including 45 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0094 ( 24 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 21 hom. )

Consequence

STXBP2
NM_006949.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 0.915

Publications

3 publications found
Variant links:
Genes affected
STXBP2 (HGNC:11445): (syntaxin binding protein 2) This gene encodes a member of the STXBP/unc-18/SEC1 family. The encoded protein is involved in intracellular trafficking, control of SNARE (soluble NSF attachment protein receptor) complex assembly, and the release of cytotoxic granules by natural killer cells. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2013]
STXBP2 Gene-Disease associations (from GenCC):
  • familial hemophagocytic lymphohistiocytosis 5
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • hereditary hemophagocytic lymphohistiocytosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • microvillus inclusion disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 19-7642483-G-A is Benign according to our data. Variant chr19-7642483-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 260110.
BP7
Synonymous conserved (PhyloP=0.915 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00939 (1431/152342) while in subpopulation AFR AF = 0.0313 (1302/41568). AF 95% confidence interval is 0.0299. There are 24 homozygotes in GnomAd4. There are 696 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 24 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STXBP2NM_006949.4 linkc.849G>A p.Glu283Glu synonymous_variant Exon 10 of 19 ENST00000221283.10 NP_008880.2 Q15833-1Q53GF4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STXBP2ENST00000221283.10 linkc.849G>A p.Glu283Glu synonymous_variant Exon 10 of 19 1 NM_006949.4 ENSP00000221283.4 Q15833-1
ENSG00000268400ENST00000698368.1 linkn.*952G>A non_coding_transcript_exon_variant Exon 12 of 20 ENSP00000513686.1 A0A8V8TM65
ENSG00000268400ENST00000698368.1 linkn.*952G>A 3_prime_UTR_variant Exon 12 of 20 ENSP00000513686.1 A0A8V8TM65

Frequencies

GnomAD3 genomes
AF:
0.00939
AC:
1429
AN:
152224
Hom.:
24
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0313
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00307
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00885
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00860
GnomAD2 exomes
AF:
0.00310
AC:
779
AN:
251334
AF XY:
0.00238
show subpopulations
Gnomad AFR exome
AF:
0.0330
Gnomad AMR exome
AF:
0.00153
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00805
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000105
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00115
AC:
1688
AN:
1461736
Hom.:
21
Cov.:
35
AF XY:
0.00102
AC XY:
745
AN XY:
727198
show subpopulations
African (AFR)
AF:
0.0331
AC:
1109
AN:
33480
American (AMR)
AF:
0.00179
AC:
80
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.00524
AC:
208
AN:
39700
South Asian (SAS)
AF:
0.000545
AC:
47
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53270
Middle Eastern (MID)
AF:
0.00399
AC:
23
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000558
AC:
62
AN:
1112010
Other (OTH)
AF:
0.00262
AC:
158
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
121
242
363
484
605
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00939
AC:
1431
AN:
152342
Hom.:
24
Cov.:
32
AF XY:
0.00934
AC XY:
696
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.0313
AC:
1302
AN:
41568
American (AMR)
AF:
0.00307
AC:
47
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00887
AC:
46
AN:
5184
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000176
AC:
12
AN:
68034
Other (OTH)
AF:
0.00851
AC:
18
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
72
144
215
287
359
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00442
Hom.:
5
Bravo
AF:
0.0100
Asia WGS
AF:
0.0120
AC:
42
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Familial hemophagocytic lymphohistiocytosis Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial hemophagocytic lymphohistiocytosis 5 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammatory syndrome Benign:1
May 01, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
1.2
DANN
Benign
0.34
PhyloP100
0.92
PromoterAI
0.0098
Neutral
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
3.8
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34450592; hg19: chr19-7707369; API